Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Progressive supranuclear palsy: in vivo SPECT imaging of presynaptic vesicular acetylcholine transporter with [123I]-iodobenzovesamicol.

Mazère J, Meissner WG, Mayo W, Sibon I, Lamare F, Guilloteau D, Tison F, Allard M.

Radiology. 2012 Nov;265(2):537-43. doi: 10.1148/radiol.12112650. Epub 2012 Sep 25.

PMID:
23012462
2.

123I-Iodobenzovesamicol SPECT Imaging of Cholinergic Systems in Dementia with Lewy Bodies.

Mazère J, Lamare F, Allard M, Fernandez P, Mayo W.

J Nucl Med. 2017 Jan;58(1):123-128. doi: 10.2967/jnumed.116.176180. Epub 2016 Jul 28.

PMID:
27469360
3.

Simplified Quantification Method for In Vivo SPECT Imaging of the Vesicular Acetylcholine Transporter with 123I-Iodobenzovesamicol.

Mazère J, Mayo W, Pariscoat G, Schulz J, Allard M, Fernandez P, Lamare F.

J Nucl Med. 2015 Jun;56(6):862-8. doi: 10.2967/jnumed.114.147074. Epub 2015 Apr 23.

4.

[(123)I]-IBVM SPECT imaging of cholinergic systems in multiple system atrophy: A specific alteration of the ponto-thalamic cholinergic pathways (Ch5-Ch6).

Mazere J, Meissner WG, Sibon I, Lamare F, Tison F, Allard M, Mayo W.

Neuroimage Clin. 2013 Aug 8;3:212-7. doi: 10.1016/j.nicl.2013.07.012. eCollection 2013.

5.

Effects of long-term hormone therapy on cholinergic synaptic concentrations in healthy postmenopausal women.

Smith YR, Minoshima S, Kuhl DE, Zubieta JK.

J Clin Endocrinol Metab. 2001 Feb;86(2):679-84.

PMID:
11158031
6.

Topography of dopamine transporter availability in progressive supranuclear palsy: a voxelwise [123I]beta-CIT SPECT analysis.

Seppi K, Scherfler C, Donnemiller E, Virgolini I, Schocke MF, Goebel G, Mair KJ, Boesch S, Brenneis C, Wenning GK, Poewe W.

Arch Neurol. 2006 Aug;63(8):1154-60.

PMID:
16908744
7.

(E)-[125I]-5-AOIBV: a SPECT radioligand for the vesicular acetylcholine transporter.

Emond P, Mavel S, Zea-Ponce Y, Kassiou M, Garreau L, Bodard S, Drossard ML, Chalon S, Guilloteau D.

Nucl Med Biol. 2007 Nov;34(8):967-71. Epub 2007 Sep 19.

PMID:
17998100
8.

Comparison of noninvasive quantification methods of in vivo vesicular acetylcholine transporter using [123I]-IBVM SPECT imaging.

Barret O, Mazère J, Seibyl J, Allard M.

J Cereb Blood Flow Metab. 2008 Sep;28(9):1624-34. doi: 10.1038/jcbfm.2008.53. Epub 2008 May 28.

PMID:
18506194
9.

123I-FP-CIT in progressive supranuclear palsy and in Parkinson's disease: a SPECT semiquantitative study.

Filippi L, Manni C, Pierantozzi M, Brusa L, Danieli R, Stanzione P, Schillaci O.

Nucl Med Commun. 2006 Apr;27(4):381-6.

PMID:
16531926
10.

In vivo mapping of cholinergic neurons in the human brain using SPECT and IBVM.

Kuhl DE, Koeppe RA, Fessler JA, Minoshima S, Ackermann RJ, Carey JE, Gildersleeve DL, Frey KA, Wieland DM.

J Nucl Med. 1994 Mar;35(3):405-10.

11.

In vivo SPECT imaging of vesicular acetylcholine transporter using [(123)I]-IBVM in early Alzheimer's disease.

Mazère J, Prunier C, Barret O, Guyot M, Hommet C, Guilloteau D, Dartigues JF, Auriacombe S, Fabrigoule C, Allard M.

Neuroimage. 2008 Mar 1;40(1):280-8. doi: 10.1016/j.neuroimage.2007.11.028. Epub 2007 Dec 3.

PMID:
18191587
12.

Cholinergic vesicular transporters in progressive supranuclear palsy.

Suzuki M, Desmond TJ, Albin RL, Frey KA.

Neurology. 2002 Apr 9;58(7):1013-8.

PMID:
11940684
13.

Correlation of the vesicular acetylcholine transporter densities in the striata to the clinical abilities of women with Rett syndrome.

Brašić JR, Bibat G, Kumar A, Zhou Y, Hilton J, Yablonski ME, Dogan AS, Guevara MR, Stephane M, Johnston M, Wong DF, Naidu S.

Synapse. 2012 Jun;66(6):471-82. doi: 10.1002/syn.21515. Epub 2012 Feb 28.

14.

Obstructive sleep apnea is related to a thalamic cholinergic deficit in MSA.

Gilman S, Chervin RD, Koeppe RA, Consens FB, Little R, An H, Junck L, Heumann M.

Neurology. 2003 Jul 8;61(1):35-9.

PMID:
12847153
15.
16.

Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy.

Oh M, Kim JS, Kim JY, Shin KH, Park SH, Kim HO, Moon DH, Oh SJ, Chung SJ, Lee CS.

J Nucl Med. 2012 Mar;53(3):399-406. doi: 10.2967/jnumed.111.095224. Epub 2012 Feb 9.

17.

Identification by [99mTc]ECD SPECT of anterior cingulate hypoperfusion in progressive supranuclear palsy, in comparison with Parkinson's disease.

Varrone A, Pagani M, Salvatore E, Salmaso D, Sansone V, Amboni M, Nobili F, De Michele G, Filla A, Barone P, Pappatà S, Salvatore M.

Eur J Nucl Med Mol Imaging. 2007 Jul;34(7):1071-81. Epub 2007 Jan 24.

PMID:
17245531
18.

A novel computer-assisted image analysis of [123I]β-CIT SPECT images improves the diagnostic accuracy of parkinsonian disorders.

Goebel G, Seppi K, Donnemiller E, Warwitz B, Wenning GK, Virgolini I, Poewe W, Scherfler C.

Eur J Nucl Med Mol Imaging. 2011 Apr;38(4):702-10. doi: 10.1007/s00259-010-1681-0. Epub 2010 Dec 21.

PMID:
21174092
19.

Differential distribution of striatal [123I]beta-CIT in Parkinson's disease and progressive supranuclear palsy, evaluated with single-photon emission tomography.

Messa C, Volonté MA, Fazio F, Zito F, Carpinelli A, d'Amico A, Rizzo G, Moresco RM, Paulesu E, Franceschi M, Lucignani G.

Eur J Nucl Med. 1998 Sep;25(9):1270-6.

PMID:
9724376
20.

Comparison of striatal dopamine D2 receptors in Parkinson's disease and progressive supranuclear palsy patients using [123I] iodobenzofuran single-photon emission computed tomography.

Oyanagi C, Katsumi Y, Hanakawa T, Hayashi T, Thuy Dh, Hashikawa K, Nagahama Y, Fukuyama H, Shibasaki H.

J Neuroimaging. 2002 Oct;12(4):316-24.

PMID:
12380478

Supplemental Content

Support Center